In conclusion, the results presented here provide substantial evidence that soluble PD-1 could be a promising novel biomarker predicting severe GvHD and inferior survival after HSCT and opens up the discussion about the functional role of sPD-1 molecules in HSCT. Here, HOXD13 is linked to graft versus host disease.